Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Hyperbaric oxygen therapy improves hair growth and quality of life in androgenic alopecia patients.

Finasteride improves acne and hair loss in women with normal testosterone.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Higher RBP4 levels found in people with two types of hair loss.

Many people with hair loss had low iron and ferritin levels.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Objective assessment is needed to accurately determine medication use and adherence.

Iron deficiency is not a significant cause of hair loss in women.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Ingesting Leucaena leucocephala caused hair loss and increased infant mortality in ringtailed lemurs.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Hair loss in postmenopausal woman caused by ovarian issue.